Squarepoint’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$329K Buy
194,405
+101,649
+110% +$180K ﹤0.01% 3637
2025
Q4
$132K Buy
+92,756
New +$135K ﹤0.01% 3986
2025
Q3
Sell
-41,058
Closed -$30K 4433
2025
Q2
$30K Buy
+41,058
New +$35.4K ﹤0.01% 4362
2024
Q3
Sell
-10,214
Closed -$17.7K 4180
2024
Q2
$17.7K Sell
10,214
-57,364
-85% -$115K ﹤0.01% 3967
2024
Q1
$162K Sell
67,578
-93,547
-58% -$230K ﹤0.01% 3683
2023
Q4
$537K Buy
+161,125
New +$432K ﹤0.01% 2958
2023
Q3
Sell
-285,338
Closed -$1.22M 3844
2023
Q2
$1.22M Buy
285,338
+197,489
+225% +$1.17M 0.01% 2019
2023
Q1
$601K Buy
87,849
+54,284
+162% +$421K ﹤0.01% 2197
2022
Q4
$266K Sell
33,565
-38,946
-54% -$300K ﹤0.01% 2633
2022
Q3
$697K Buy
+72,511
New +$734K 0.01% 2008
2021
Q3
Sell
-116,257
Closed -$1.61M 2965
2021
Q2
$1.61M Buy
+116,257
New +$1.65M 0.01% 1317
2021
Q1
Sell
-22,254
Closed -$387K 3170
2020
Q4
$387K Buy
+22,254
New +$396K ﹤0.01% 2019
2020
Q3
Sell
-16,280
Closed -$291K 2514
2020
Q2
$291K Sell
16,280
-90,085
-85% -$1.52M ﹤0.01% 1621
2020
Q1
$1.73M Buy
106,365
+13,841
+15% +$256K 0.05% 499
2019
Q4
$1.67M Buy
92,524
+62,683
+210% +$1.16M 0.01% 1018
2019
Q3
$605K Sell
29,841
-49,732
-62% -$994K 0.01% 1516
2019
Q2
$1.76M Buy
79,573
+4,184
+6% +$72.7K 0.02% 919
2019
Q1
$1.03M Buy
+75,389
New +$1.01M 0.01% 1097
2018
Q4
Sell
-20,780
Closed -$343K 1966
2018
Q3
$343K Buy
+20,780
New +$368K ﹤0.01% 1470
2018
Q1
Sell
-23,032
Closed -$203K 1734
2017
Q4
$203K Buy
23,032
+6,740
+41% +$72.2K ﹤0.01% 1786
2017
Q3
$217K Sell
16,292
-47,278
-74% -$625K ﹤0.01% 1345
2017
Q2
$912K Buy
63,570
+53,711
+545% +$1.03M 0.02% 759
2017
Q1
$209K Buy
+9,859
New +$243K 0.01% 1268
2016
Q1
Sell
-10,700
Closed -$246K 1200
2015
Q4
$246K Buy
+10,700
New +$275K 0.03% 895

Other funds holding CHRS